- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier på Kampforstyrrelser
Totalt 144963 resultater
-
Bambino Gesù Hospital and Research InstituteFullførtAttention Deficit Hyperactivity DisorderItalia
-
Otsuka Pharmaceutical Development & Commercialization...FullførtAttention Deficit Hyperactivity DisorderForente stater
-
National Taiwan University HospitalFullførtAttention-deficit/Hyperactivity DisorderTaiwan
-
ShireFullførtAttention Deficit Hyperactivity DisorderSpania, Forente stater, Tyskland, Polen, Italia, Ukraina, Romania, Storbritannia, Sverige, Østerrike, Canada, Frankrike, Irland
-
ShireFullførtAttention-Deficit/Hyperactivity Disorder
-
Merck Sharp & Dohme LLCFullførtAttention Deficit Hyperactivity Disorder
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR)UkjentAttention Deficit Hyperactivity DisorderCanada
-
Hadassah Medical OrganizationFullførtAttention Deficit Hyperactivity DisorderIsrael
-
Wake Forest University Health SciencesFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Mensia Technologies SAEuropean Union H2020 SME InstrumentUkjentAttention Deficit-Hyperactivity DisorderFrankrike, Belgia, Tyskland, Spania, Sveits
-
Indiana UniversityNational Library of Medicine (NLM)FullførtAttention Deficit Hyperactivity DisorderForente stater
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderForente stater, Canada, Puerto Rico
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderKorea, Republikken, Taiwan, Japan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderAustralia, Storbritannia, Mexico
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderJapan
-
Hartford HospitalYale UniversityFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderTyskland
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderItalia, Spania, Frankrike, Belgia, Tyrkia, Irland, Mexico, Norge, Storbritannia
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderTaiwan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderStorbritannia
-
National Taiwan University HospitalRekrutteringAttention Deficit Hyperactivity DisorderTaiwan
-
Dr. Martin A. KatzmanRekrutteringAttention Deficit Hyperactivity DisorderCanada
-
Eastern Mediterranean UniversityFullførtAttention Deficit Hyperactivity DisorderKypros
-
University of California, IrvineFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Oregon Health and Science UniversityFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Materia Medica HoldingFullførtAttention Deficit Hyperactivity DisorderDen russiske føderasjonen
-
Hospital de Clinicas de Porto AlegreFullførtAttention Deficit Hyperactivity DisorderBrasil
-
Purdue Pharma, CanadaFullførtAttention Deficit-Hyperactivity DisorderCanada
-
Allameh Tabatabai UniversityFullførtAttention Deficit Hyperactivity DisorderIran, den islamske republikken
-
Universiti Tunku Abdul RahmanUniversiti Putra MalaysiaUkjentAttention-deficit hyperactivity disorderMalaysia
-
Hospital de Clinicas de Porto AlegreUkjentAttention Deficit Hyperactivity DisorderBrasil
-
Karakter Kinder- en JeugdpsychiatrieRadboud University Medical Center; University of Amsterdam; European Commission og andre samarbeidspartnereFullførtAttention Deficit Hyperactivity DisorderNederland
-
Columbia UniversityFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Boston Children's HospitalNeuroscouting, L.L.C.FullførtAttention Deficit Hyperactivity DisorderForente stater
-
University of ZurichSwiss National Science FoundationFullførtAttention Deficit Hyperactivity DisorderSveits
-
Boston Medical CenterCodman Square Health Center; Dorchester House Health CenterFullførtAttention Deficit/Hyperactivity DisorderForente stater
-
University of California, Los AngelesNeuroSigma, Inc.FullførtAttention-Deficit/Hyperactivity DisorderForente stater
-
North Essex Partnership NHS Foundation TrustUniversity College, London; Hertfordshire Community NHS TrustUkjentAttention Deficit/Hyperactivity DisorderStorbritannia
-
Samsung Medical CenterSamsung ElectronicsUkjentAttention Deficit Hyperactivity DisorderKorea, Republikken
-
Hospital Universitari Vall d'Hebron Research InstituteFullførtAttention Deficit Hyperactivity DisorderSpania
-
University of TorontoUkjent
-
Charite University, Berlin, GermanyMediTECH Electronic GmbH; AudioProfiling, Dr. Joerg LangnerUkjentAttention-Deficit/Hyperactivity DisorderTyskland
-
University of British ColumbiaEli Lilly and Company; Shire; Purdue Pharma LPFullførtAttention-Deficit/Hyperactivity DisorderCanada
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderForente stater, Puerto Rico
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderSpania
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderKorea, Republikken
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderForente stater